Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h


+3226269640
Google maps


Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :
TAGS

22/04/2016
Interferon-based therapy improves clinical outcomes in hepatitis delta infection

BARCELONA — Patients with hepatitis delta virus infection treated with pegylated interferon alpha were less likely to develop clinical outcomes — like decompensation or hepatocellular carcinoma — compared with patients who received nucleos(t)ide-based treatment or no treatment at all, according to a presentation at International Liver Congress....

Read more...

Source Source: Healio

Tags: Hepatitis




22/04/2016
Multiple social and health factors associated with irregular attendance at London HIV clinics

One-size-fits-all approach to improving engagement with care unlikely to be effective People who miss appointments for HIV care are more likely to have money problems, childcare responsibilities and a history of depression according to a recent UK study.  While poor attendance was more common in women, other demographic factors including ethnicity and...

Read more...

Source Source: Aidsmap





22/04/2016
Researchers uncover 'local heroes' of immune system

Melbourne researchers have uncovered genes responsible for the way the body fights infection at the point of ‘invasion’ – whether it's the skin, liver, lungs or the gut. Research led by Dr Axel Kallies and Dr Klaas van Gisbergen at the Walter and Eliza Hall Institute of Medical Research, and Dr Laura Mackay from the University of Melbourne at the Peter...

Read more...





22/04/2016
EMA: Integrating patients’ views in clinical studies of anticancer medicines

EMA publishes new guidance on the use of patient-reported outcome measures in oncology studies The European Medicines Agency (EMA) has published new guidance on the use of patient-reported outcome (PRO) measures in oncology studies. The new guidance is an appendix to the guideline on the evaluation of anticancer medicinal products in man, which was last revised in July 2013....

Read more...

Source Source: EMA





21/04/2016
Global Fund: Statement on the UN Special Session on world drug problem

The Global Fund to Fight AIDS, Tuberculosis and Malaria welcomes the UN General Assembly Special Session on the world drug problem as an opportunity to bring public health and human rights concerns at the center of the current debate. We welcome this meeting as an opportunity to shape drug policies that facilitate good health outcomes. Good drug policy can help in many ways: by...

Read more...